Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion

被引:26
|
作者
Dolan, Michelle [3 ]
Cioc, Adina [3 ]
Cross, Nicholas C. P. [4 ,5 ]
Neglia, Joseph P. [1 ,2 ]
Tolar, Jakub [1 ,2 ]
机构
[1] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, 420 Delaware St SE,MMC 366, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Pediat, Div Hematol Oncol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[4] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England
[5] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
关键词
BCR; BCR-FGFR1 gene fusion; FGFR1; hematopoietic cell transplantation; 8p11 myeloproliferative syndrome; LYMPHOBLASTIC LYMPHOMA; INTERFERON-ALPHA; DISORDER; EOSINOPHILIA; PATIENT; FGFR1; TRANSLOCATIONS; MALIGNANCY; LEUKEMIA; T(8/22);
D O I
10.1002/pbc.23404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the case of a child who presented with nonspecific symptoms suggestive of a rheumatologic disorder, whose bone marrow had a complex translocation involving the FGFR1 locus. Hematopathologic findings were subtle and did not definitively indicate malignancy. Because he responded poorly to initial treatment with hydroxyurea, and in light of the progressive clinical course associated with the 8p11 myeloproliferative syndrome, he underwent an unrelated-donor hematopoietic stem cell transplant. This patient's atypical presentation highlights the importance of obtaining cytogenetic analysis at the time of bone marrow sampling and considering this uncommon entity in the differential diagnosis of hematologic disorders. Pediatr Blood Cancer 2012; 59: 194196. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:194 / 196
页数:3
相关论文
共 50 条
  • [11] LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome
    Soler, G.
    Nusbaum, S.
    Varet, B.
    Macintyre, E. A.
    Vekemans, M.
    Romana, S. P.
    Radford-Weiss, I.
    LEUKEMIA, 2009, 23 (07) : 1359 - 1361
  • [12] Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome
    Chase, Andrew
    Bryant, Catherine
    Score, Joannah
    Cross, Nicholas C. P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2013, 98 (01): : 103 - 106
  • [13] 8p11 myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: A case report and review of the literature
    Kim, Seon Young
    Oh, Bora
    She, Cha Ja
    Kim, Hyun Kyung
    Jeon, Yoon Kyung
    Shin, Myung-Geun
    Yoon, Sung-Soo
    Lee, Dong Soon
    LEUKEMIA RESEARCH, 2011, 35 (05) : E30 - E34
  • [14] Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome
    Li, Feng
    Zhai, Yong-Ping
    Tang, Yu-Mei
    Wang, Li-Ping
    Wan, Pin-Jun
    GENES CHROMOSOMES & CANCER, 2012, 51 (09): : 890 - 897
  • [15] Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib
    Landberg, Niklas
    Dreimane, Arta
    Rissler, Marianne
    Billstrom, Rolf
    Agerstam, Helena
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (05) : 442 - 448
  • [16] Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome
    Grand, EK
    Grand, FH
    Chase, AJ
    Ross, FM
    Corcoran, MM
    Oscier, DG
    Cross, NCP
    GENES CHROMOSOMES & CANCER, 2004, 40 (01): : 78 - 83
  • [17] Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion
    Murati, A
    Arnoulet, C
    Lafage-Pochitaloff, M
    Adélaide, J
    Derré, M
    Slama, B
    Delaval, B
    Popovici, C
    Vey, N
    Xerri, L
    Mozziconacci, MJ
    Boulat, O
    Sainty, D
    Birnbaum, D
    Chaffanet, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (06) : 1485 - 1492
  • [18] Functional Characterization, Localization, and Inhibitor Sensitivity of the TPR-FGFR1 Fusion in 8p11 Myeloproliferative Syndrome
    Malli, Theodora
    Buxhofer-Ausch, Veronika
    Rammer, Melanie
    Erdel, Martin
    Kranewitter, Wolfgang
    Rumpold, Holger
    Marschon, Renate
    Deutschbauer, Sabine
    Simonitsch-Klupp, Ingrid
    Valent, Peter
    Muellner-Ammer, Kirsten
    Sebesta, Christian
    Birkner, Thomas
    Webersinke, Gerald
    GENES CHROMOSOMES & CANCER, 2016, 55 (01): : 60 - 68
  • [19] Activity of TK1258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome
    Chase, Andrew
    Grand, Francis H.
    Cross, Nicholas C. P.
    BLOOD, 2007, 110 (10) : 3729 - 3734
  • [20] Quantitative polymerase chain reaction detection of CEP110-FGFR1 fusion gene in a patient with 8p11 myeloproliferative syndrome
    Yamamoto, Shohei
    Ebihara, Yasuhiro
    Mochizuki, Shinji
    Kawakita, Toshiro
    Kato, Seiko
    Ooi, Jun
    Takahashi, Satoshi
    Tojo, Arinobu
    Yusa, Nozomi
    Furukawa, Yoichi
    Oyaizu, Naoki
    Watanabe, Junichi
    Sato, Ken
    Kimura, Fumihiko
    Tsuji, Kohichiro
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2068 - 2069